Terumo Corporation · TSE:4543
Terumo — FY2012 Earnings Presentation
9 slides from Terumo's earnings presentation, May 10, 2012
Slide 1: Management Priorities
Management Priorities Terumo Corporation President & Representative Director Yutaro Shintaku May 10, 2012
Slide 2: Management Priorities
Management Priorities 1. Solid Business Continuity Plan (BCP) and stability of product supply 2. Investment in production to enable sustainable business growth and enhance cost competitiveness 3. Strategic shift in business portofolio 4. Investment in quality management system of CV business (US) 5.
Slide 3: 1. BCP & Stability of Product Supply
1. BCP & Stability of Product Supply Emergency power generators Installed 5 in-house power generators used in previous year Data center integrity (one in eastern JP, one in western JP) Two customer service centers (one in eastern JP, one in western JP) New Yamaguchi factory In-house power ge
Slide 4: 2. Investment in production
2. Investment in production Vietnam Hanoi: a new building to expand production of interventional products Southern Vietnam: a new factory to produce blood management products The Philippines A new production building to expand production of general hospital products such as syringes and ne
Slide 5: 3. Strategic Shift in Business Portfolio
3. Strategic Shift in Business Portfolio Over half of the total sales now comes from highly profitable businesses growing at double digit rate Cardiac & Vascular and Blood Management High expectation on new products of General Hospital business (billion of yen) Sales Composition 400 Blood Mana
Slide 6: 4. Investment in Quality Management System (U.S.-TCVS)
4. Investment in Quality Management System(U.S.-TCVS) Improvement works in good progress, in accordance with consent decree agreed with U.S. FDA in Sep, 2011 The similar level of investment to one in FYE Mar. 2012 will be continuously made in FYE Mar. 2013 It will complete in Spring of 2013, a
Slide 7: 5. Investment in Growth Strategy & Shareholders Return
5. Investment in Growth Strategy & Shareholders Return Target for next 5 years Operating Investment & Financial Cash Flow Cash Flow Depreciation & Repayment Amortization of debts minus Balancing between Working Capital increase investment in growth and repayment of debts Investment in sustainable gr
Slide 8: Steadily Increasing Global Presence
Steadily Increasing Global Presence Ranking of World Med-Tech Companies （Excl. diagnostic imaging companies） （US$B） st 1 J&J 24.6 2nd Medtronic 15.8 3rd Baxter 12.8 4th Fresenius 12.1 5th Abbott 9.3 6th Covidien 8.4 7th Boston 7.8 8th BD 7.4 9th Stryker 7.3 10th B.Braun 5.9 11th St. Jude 5.2 FYE Mar
Slide 9: IR Contact
IR Contact Terumo Corporation Corporate Communication (IR) Dept. E-mail: [email protected] Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not i